Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 361 AL 375

Therapeutic news in Alzheimer's disease: Soon a disease-modifying therapy?

Villain N.

Rev Neurol (Paris). 2022 May;178(5):437-440. doi: 10.1016/j.neurol.2022.02.456. Epub 2022 Apr 28.

Promise of irisin to attenuate cognitive dysfunction in aging and Alzheimer's disease

Madhu LN, Somayaji Y, Shetty AK.

Ageing Res Rev. 2022 Jun;78:101637. doi: 10.1016/j.arr.2022.101637. Epub 2022 Apr 30.

Screening neuroprotective compounds in herpes-induced Alzheimer's disease cell and 3D tissue models

Silveira IA, Mullis AS, Cairns DM, Shevzov-Zebrun A, Whalen J, Galuppo A, Walsh KG, Kaplan DL.

Free Radic Biol Med. 2022 Jun;186:76-92. doi: 10.1016/j.freeradbiomed.2022.05.002. Epub 2022 May 7.

Cognitive Stimulation in Moderate Alzheimer's Disease

Gonzalez-Moreno J, Satorres E, Soria-Urios G, Meléndez JC.

J Appl Gerontol. 2022 Aug;41(8):1934-1941. doi: 10.1177/07334648221089283. Epub 2022 May 27.

Testosterone, cognitive decline and dementia in ageing men

Yeap BB, Flicker L.

Rev Endocr Metab Disord. 2022 Dec;23(6):1243-1257. doi: 10.1007/s11154-022-09728-7. Epub 2022 May 28.

Cortical excitability and plasticity in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis of transcranial magnetic stimulation studies

Chou YH, Sundman M, Ton That V, Green J, Trapani C.

Ageing Res Rev. 2022 Aug;79:101660. doi: 10.1016/j.arr.2022.101660. Epub 2022 Jun 6.

Overview of therapeutic targets in management of dementia

Malik R, Kalra S, Bhatia S, Harrasi AA, Singh G, Mohan S, Makeen HA, Albratty M, Meraya A, Bahar B, Tambuwala MM.

Biomed Pharmacother. 2022 Aug;152:113168. doi: 10.1016/j.biopha.2022.113168. Epub 2022 Jun 11.

ALZT-OP1: an experimental combination regimen for the treatment of Alzheimer's disease

Lozupone M, Berardino G, Mollica A, Sardone R, Dibello V, Zupo R, Lampignano L, Castellana F, Bortone I, Stallone R, Daniele A, Altamura M, Bellomo A, Solfrizzi V, Panza F.

Expert Opin Investig Drugs. 2022 Aug;31(8):759-771. doi: 10.1080/13543784.2022.2095261. Epub 2022 Jun 29.

AXS-05: an investigational treatment for Alzheimer's disease-associated agitation

Ward K, Citrome L.

Expert Opin Investig Drugs. 2022 Aug;31(8):773-780. doi: 10.1080/13543784.2022.2096006. Epub 2022 Jul 6.

Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project

Toups K, Hathaway A, Gordon D, Chung H, Raji C, Boyd A, Hill BD, Hausman-Cohen S, Attarha M, Chwa WJ, Jarrett M, Bredesen DE.

J Alzheimers Dis. 2022;88(4):1411-1421. doi: 10.3233/JAD-215707.

Cannabinoid extract in microdoses ameliorates mnemonic and nonmnemonic Alzheimer's disease symptoms: a case report

Ruver-Martins AC, Bicca MA, de Araujo FS, de Noronha Sales Maia BHL, Pamplona FA, da Silva EG, Nascimento FP.

J Med Case Rep. 2022 Jul 12;16(1):277. doi: 10.1186/s13256-022-03457-w.

Fatty Acids: A Safe Tool for Improving Neurodevelopmental Alterations in Down Syndrome?

Martínez-Cué C, Bartesaghi R.

Nutrients. 2022 Jul 13;14(14):2880. doi: 10.3390/nu14142880.

Effects of Selenium Supplementation in Patients with Mild Cognitive Impairment or Alzheimer's Disease: A Systematic Review and Meta-Analysis

Pereira ME, Souza JV, Galiciolli MEA, Sare F, Vieira GS, Kruk IL, Oliveira CS.

Nutrients. 2022 Aug 5;14(15):3205. doi: 10.3390/nu14153205.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias